|
|
|
Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 51-60
|
|
Carboplatin and paclitaxel in non-small cell lung cancer: The role of amifostine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIFOSTINE;
CARBOPLATIN;
PACLITAXEL;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
BONE MARROW TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG EFFECT;
DRUG EFFICACY;
HUMAN;
LUNG NON SMALL CELL CANCER;
MULTICENTER STUDY;
NEUROTOXICITY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
AMIFOSTINE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW DISEASES;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CYTOPROTECTION;
HUMANS;
LUNG NEOPLASMS;
NERVOUS SYSTEM DISEASES;
PACLITAXEL;
PROTECTIVE AGENTS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0033033044
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (15)
|
|
References (85)
|
